Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Copper-dependent amino oxidase 3 governs selection of metabolic fuels in adipocytes.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Additional Information
- Source:
Publisher: Public Library of Science Country of Publication: United States NLM ID: 101183755 Publication Model: eCollection Cited Medium: Internet ISSN: 1545-7885 (Electronic) Linking ISSN: 15449173 NLM ISO Abbreviation: PLoS Biol Subsets: MEDLINE
- Publication Information:
Original Publication: San Francisco, CA : Public Library of Science, [2003]-
- Subject Terms:
- Abstract:
Copper (Cu) has emerged as an important modifier of body lipid metabolism. However, how Cu contributes to the physiology of fat cells remains largely unknown. We found that adipocytes require Cu to establish a balance between main metabolic fuels. Differentiating adipocytes increase their Cu uptake along with the ATP7A-dependent transport of Cu into the secretory pathway to activate a highly up-regulated amino-oxidase copper-containing 3 (AOC3)/semicarbazide-sensitive amine oxidase (SSAO); in vivo, the activity of SSAO depends on the organism's Cu status. Activated SSAO oppositely regulates uptake of glucose and long-chain fatty acids and remodels the cellular proteome to coordinate changes in fuel availability and related downstream processes, such as glycolysis, de novo lipogenesis, and sphingomyelin/ceramide synthesis. The loss of SSAO-dependent regulation due to Cu deficiency, limited Cu transport to the secretory pathway, or SSAO inactivation shifts metabolism towards lipid-dependent pathways and results in adipocyte hypertrophy and fat accumulation. The results establish a role for Cu homeostasis in adipocyte metabolism and identify SSAO as a regulator of energy utilization processes in adipocytes.
Competing Interests: The authors have declared that no competing interests exist.
- References:
J Biol Chem. 2004 Jul 23;279(30):31902-9. (PMID: 15131120)
Gastroenterology. 2018 Jan;154(1):168-180.e5. (PMID: 28958857)
J Physiol Biochem. 2012 Dec;68(4):651-62. (PMID: 22547093)
Am J Clin Nutr. 1998 May;67(5 Suppl):1029S-1034S. (PMID: 9587147)
Biochemistry. 2001 Mar 6;40(9):2954-63. (PMID: 11258907)
J Anim Sci. 2011 Feb;89(2):591-6. (PMID: 20935142)
Biochem J. 2000 Aug 15;350 Pt 1:171-80. (PMID: 10926841)
Pharmacol Res. 2010 Apr;61(4):355-63. (PMID: 20045461)
Am J Transplant. 2010 May;10(5):1325-9. (PMID: 20346064)
J Neural Transm (Vienna). 2007;114(6):829-33. (PMID: 17406965)
Pediatr Int. 1999 Aug;41(4):423-9. (PMID: 10453199)
Biochem J. 2001 Sep 1;358(Pt 2):335-42. (PMID: 11513731)
Am J Gastroenterol. 2010 Sep;105(9):1978-85. (PMID: 20407430)
Nat Commun. 2016 Feb 16;7:10640. (PMID: 26879543)
Respir Res. 2009 May 04;10:33. (PMID: 19413900)
Am J Pathol. 2009 Mar;174(3):1075-83. (PMID: 19218346)
Mol Cell Biol. 2003 Feb;23(3):1085-94. (PMID: 12529412)
J Clin Invest. 2001 Apr;107(8):929-34. (PMID: 11306593)
Mol Med. 2015 Feb 23;21:26-37. (PMID: 25730773)
J Biol Chem. 1997 Apr 4;272(14):9388-92. (PMID: 9083076)
J Histochem Cytochem. 2001 Feb;49(2):209-17. (PMID: 11156689)
J Biol Chem. 1957 May;226(1):497-509. (PMID: 13428781)
J Neuroimmune Pharmacol. 2011 Dec;6(4):640-9. (PMID: 21748284)
Med Electron Microsc. 2002 Jun;35(2):61-6. (PMID: 12181646)
J Proteome Res. 2013 Feb 1;12(2):594-604. (PMID: 23270375)
J Immunol. 2011 Apr 15;186(8):4915-24. (PMID: 21411731)
Neurology. 2007 May 1;68(18):1481-7. (PMID: 17470750)
J Biol Chem. 1998 Apr 3;273(14):8025-32. (PMID: 9525902)
J Biol Chem. 2016 Aug 5;291(32):16644-58. (PMID: 27226607)
Ann Nutr Metab. 1985;29(6):332-47. (PMID: 4062244)
Aging Cell. 2015 Feb;14(1):112-21. (PMID: 25345489)
Biol Trace Elem Res. 2006 Winter;114(1-3):19-29. (PMID: 17205984)
J Biol Chem. 2007 Mar 16;282(11):8343-55. (PMID: 17205981)
Biol Pharm Bull. 2005 Mar;28(3):413-8. (PMID: 15744061)
PLoS One. 2014 Mar 10;9(3):e90544. (PMID: 24614111)
Clin Biochem. 2010 Sep;43(13-14):1074-8. (PMID: 20599868)
PLoS One. 2015 Nov 10;10(11):e0142367. (PMID: 26556595)
Ann Neurol. 2004 Feb;55(2):257-67. (PMID: 14755730)
Mol Cell Biol. 2016 Jul 14;36(15):2089-104. (PMID: 27215380)
Mol Biosyst. 2007 Dec;3(12):816-24. (PMID: 18000558)
Am J Clin Exp Immunol. 2013 Jun 15;2(2):172-85. (PMID: 23885334)
J Clin Invest. 2005 Feb;115(2):291-301. (PMID: 15690082)
Neurology. 2013 Oct 22;81(17):1492-9. (PMID: 24027056)
Nat Chem Biol. 2016 Aug;12(8):586-92. (PMID: 27272565)
Diabetes. 2007 Jan;56(1):168-76. (PMID: 17192479)
J Nutr Biochem. 2015 Oct;26(10):996-1006. (PMID: 26033743)
J Clin Invest. 2015 Feb;125(2):501-20. (PMID: 25562318)
- Grant Information:
R01 DK071865 United States DK NIDDK NIH HHS; R01 DK084171 United States DK NIDDK NIH HHS; R01 NS072241 United States NS NINDS NIH HHS; R56 DK071865 United States DK NIDDK NIH HHS
- Accession Number:
0 (Atp7a protein, mouse)
0 (Fatty Acids)
0 (Triglycerides)
789U1901C5 (Copper)
EC 1.4.3.21 (Amine Oxidase (Copper-Containing))
EC 7.2.2.8 (Copper-Transporting ATPases)
IY9XDZ35W2 (Glucose)
- Publication Date:
Date Created: 20180911 Date Completed: 20190422 Latest Revision: 20241112
- Publication Date:
20241112
- Accession Number:
PMC6130853
- Accession Number:
10.1371/journal.pbio.2006519
- Accession Number:
30199530
No Comments.